{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T16:21:04Z","timestamp":1778948464572,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016987","name":"Research Center for Biomedical Engineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016987","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007428","name":"Naito Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.xphs.2022.01.018","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T05:09:50Z","timestamp":1643605790000},"page":"2116-2120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Polyrotaxane-Based Supramolecular Material for Improvement of Pharmaceutical Properties of Protein Drugs"],"prefix":"10.1016","volume":"111","author":[{"given":"Tetsuya","family":"Kogo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosei","family":"Utatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Taharabaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risako","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Motoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8439-5377","authenticated-orcid":false,"given":"Taishi","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.xphs.2022.01.018_bib0001","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/d41573-021-00050-6","article-title":"Top companies and drugs by sales in 2020","volume":"20","author":"Urquhart","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.xphs.2022.01.018_bib0002","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-5173(99)00152-0","article-title":"Instability, stabilization, and formulation of liquid protein pharmaceuticals","volume":"185","author":"Wang","year":"1999","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2022.01.018_bib0003","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrd1695","article-title":"Protein drug stability: a formulation challenge","volume":"4","author":"Frokjaer","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"6367","key":"10.1016\/j.xphs.2022.01.018_bib0004","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/356325a0","article-title":"The molecular necklace: A rotaxane containing many threaded \u03b1-cyclodextrins","volume":"356","author":"Harada","year":"1992","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.xphs.2022.01.018_bib0005","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1021\/cr970027+","article-title":"Cyclodextrin rotaxanes and polyrotaxanes","volume":"106","author":"Wenz","year":"2006","journal-title":"Chem Rev"},{"issue":"88","key":"10.1016\/j.xphs.2022.01.018_bib0006","doi-asserted-by":"crossref","first-page":"13433","DOI":"10.1039\/C4CC03709J","article-title":"Threaded macromolecules as a versatile framework for biomaterials","volume":"50","author":"Tamura","year":"2014","journal-title":"Chem Commun"},{"issue":"4","key":"10.1016\/j.xphs.2022.01.018_bib0007","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1248\/cpb.c18-00735","article-title":"Cyclodextrin-based molecular accessories for drug discovery and drug delivery","volume":"67","author":"Higashi","year":"2019","journal-title":"Chem Pharm Bull"},{"issue":"8","key":"10.1016\/j.xphs.2022.01.018_bib0008","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/mabi.201500083","article-title":"Cationic polyrotaxanes as a feasible framework for the intracellular delivery and sustainable activity of anionic enzymes: A comparison study with methacrylate-based polycations","volume":"15","author":"Tamura","year":"2015","journal-title":"Macromol Biosci"},{"key":"10.1016\/j.xphs.2022.01.018_bib0009","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1038\/srep02252","article-title":"Molecular logistics using cytocleavable polyrotaxanes for the reactivation of enzymes delivered in living cells","volume":"3","author":"Tamura","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2022.01.018_bib0010","article-title":"Polyrotaxane-based multi-step transformable materials for the delivery of Cas9 ribonucleoprotein","author":"Taharabaru","year":"2022","journal-title":"submitted"},{"key":"10.1016\/j.xphs.2022.01.018_bib0011","article-title":"Supramolecular polymer-based transformable material for reversible PEGylation of protein drugs","volume":"12","author":"Utatsu","year":"2021","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.xphs.2022.01.018_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.117419","article-title":"Polypseudorotaxane-based supramolecular hydrogels consisting of cyclodextrins and Pluronics as stabilizing agents for antibody drugs","volume":"256","author":"Ohshita","year":"2021","journal-title":"Carbohydr Polym"},{"issue":"1-2","key":"10.1016\/j.xphs.2022.01.018_bib0013","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10847-014-0407-5","article-title":"Improvement of pharmaceutical properties of insulin through conjugation with glucuronylglucosyl-\u03b2-cyclodextrin","volume":"80","author":"Hirotsu","year":"2014","journal-title":"J Incl Phenom Macrocycl Chem"},{"issue":"3","key":"10.1016\/j.xphs.2022.01.018_bib0014","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2146\/ajhp090031","article-title":"Stability of cetuximab and panitumumab in glass vials and polyvinyl chloride bags","volume":"67","author":"Ikesue","year":"2010","journal-title":"Am J Health Syst Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2022.01.018_bib0015","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1021\/bm4003046","article-title":"Trehalose glycopolymers as excipients for protein stabilization","volume":"14","author":"Lee","year":"2013","journal-title":"Biomacromolecules"},{"issue":"7","key":"10.1016\/j.xphs.2022.01.018_bib0016","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.tibtech.2014.05.005","article-title":"Therapeutic protein aggregation: Mechanisms, design, and control","volume":"32","author":"Roberts","year":"2014","journal-title":"Trends Biotechnol"},{"issue":"2","key":"10.1016\/j.xphs.2022.01.018_bib0017","first-page":"49","article-title":"Potential use of maltosyl-\u03b2-cyclodextrin for inhibition of insulin self-association in aqueous solution","volume":"1","author":"Tokihiro","year":"1995","journal-title":"Pharm Pharmacol Commun"},{"issue":"4","key":"10.1016\/j.xphs.2022.01.018_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2017.03.003","article-title":"Direct pharmacological targeting of a mitochondrial ion channel selectively kills tumor cells in vivo","volume":"31","author":"Leanza","year":"2017","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.xphs.2022.01.018_bib0019","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.apsb.2018.05.005","article-title":"Human carboxylesterases: a comprehensive review","volume":"8","author":"Wang","year":"2018","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"10.1016\/j.xphs.2022.01.018_bib0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1021\/js960213f","article-title":"Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation","volume":"86","author":"Irie","year":"1997","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2022.01.018_bib0021","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/jps.2600830432","article-title":"Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice","volume":"83","author":"Yamaoka","year":"1994","journal-title":"J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354922000272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354922000272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:37:32Z","timestamp":1758361052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354922000272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0022354922000272"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2022.01.018","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyrotaxane-Based Supramolecular Material for Improvement of Pharmaceutical Properties of Protein Drugs","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2022.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}